SCHEMBL15366209

SCHEMBL15366209

C1C[C@@H]2COC[C@H](C1)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL272458 1.00
Bromide SCHEMBL7941597 0.97 KDM4E (0.31)
Hydrochloric Acid SCHEMBL30926986 0.97 KDM4E (0.31)
Hydrochloric Acid SCHEMBL271876 0.97 KDM4E (0.31)
Hydrochloric Acid SCHEMBL17560231 0.94 KDM4E (0.30)
SCHEMBL23505786 0.94
SCHEMBL1139811 0.87
SCHEMBL22928568 0.87
SCHEMBL24405239 0.87
SCHEMBL55587 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022165529-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN BIOTECH, INC. (US) 2022-08-04 WO disclosed
EP-2847208-B1 C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY VIIV HEALTHCARE UK (NO 5) LTD (GB) 2017-10-04 EP disclosed
US-8889854-B2 C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity BRISTOL-MYERS SQUIBB COMPANY (US) 2014-11-18 US disclosed
US-20130296554-A1 C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) 2013-11-07 US disclosed